Infraredx, a Nipro Company specializes in providing advanced cardiovascular imaging technologies, including the Dualpro IVUS+NIRS catheter and the Makoto Intravascular Imaging System, which are FDA-cleared to identify patients and plaques at an increased risk of major adverse cardiac events. The company also offers the OKAY II Y-Connector, a leading product in Japan, designed to reduce blood loss. Based in Bedford, Massachusetts, Infraredx was founded in 1998 and employs 98 people.
The company's mission is to enhance the understanding of lipid core plaques and their role in heart disease, offering unparalleled insights through its innovative imaging systems. Infraredx's technology is pivotal in the early detection and management of cardiovascular risks, making it a critical player in the medical device industry.
Infraredx's commitment to innovation and quality is evident in its comprehensive product offerings and its dedication to improving patient outcomes through advanced imaging solutions.
| Ownership Private Company |
| Parent Company Nipro Corporation |
B2B professionals should contact Infraredx, a Nipro Company, for cutting-edge cardiovascular imaging solutions that enhance patient care and outcomes. Their innovative products offer significant value in the early detection and management of heart disease risk factors.
Sales teams targeting the medical device industry, healthcare providers seeking advanced imaging solutions, and partners interested in innovative cardiovascular technologies should reach out to Infraredx.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Infraredx, a Nipro Company